🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

7,387 results for “Le” Clear

  1. PEG-somatropin

    The First People's Hospital of Lianyungang

    Growth Hormone Deficiency

    approved mab active

    1 trial
  2. PLACEBO, ISMIGEN tabletki podjezykowe

    Lacuna Pharma Pty Ltd

    Respiratory Tract Infections

    approved small molecule active

    1 trial
  3. PROGRAF 1 mg capsule, Modigraf 0.2 mg granules for oral suspension, Envarsus 0.75 mg prolonged-release tablets, PROGRAF 0,5 mg capsule, Envarsus 4 mg prolonged-release tablets, Envarsus 1 mg prolonged-release tablets, PROGRAF 5 mg capsule, Modigraf 1 mg granules for oral suspension

    Disc Medicine

    pediatric kidney transplant recipients

    approved small molecule active

    1 trial
  4. PROPESS 10 mg, système de diffusion vaginal, PROSTINE E2 2 mg/3 g, gel vaginal, ANGUSTA 25 microgrammes, comprime, OXYTOCINE PANPHARMA 5 UI/1 ml, solution injectable

    Tour Hekla

    Labor Induction of women with an unfavorable Cervix after 24 hours of cervical ripening

    approved small molecule active

    1 trial
  5. PYTEST® 14C-Urea Capsule Breath Test (at Home)

    Phathom Pharmaceuticals

    H. Pylori Infection

    approved small molecule active

    1 trial
  6. Pantoprazole

    Takeda

    Gastroesophageal Reflux Disease

    approved small molecule completed

    2 trials
  7. Pantoprazole

    Takeda

    Gastroesophageal Reflux

    approved small molecule completed

    3 trials
  8. Pantoprazole Teva 40 mg maagsapresistente tabletten, Mycophenolate mofetil Sandoz 500 mg Film-coated Tablets, Mycophenolate Mofetil Accord 500 mg plėvele dengtos tabletės, CellCept 500 mg film-coated tablets

    Disc Medicine

    Post Transplantation Patients

    approved small molecule active

    1 trial
  9. Paracetamol Biofarm, 500 mg, tabletki, Placebo - Nalgesin forte, Nalgesin Forte, 550 mg, tabletki powlekane

    Novo Nordisk A/S

    Knee osteoarthritis

    approved small molecule active

    1 trial
  10. Parecoxib

    The First People's Hospital of Lianyungang

    Postoperative Pain Management, Pain Threshold, Shoulder Pain, Laparoscopies

    approved small molecule completed

    1 trial
  11. Parecoxib

    The First People's Hospital of Lianyungang

    Emergence Delirium

    approved small molecule active

    1 trial
  12. Pegylated liposomal doxorubicin

    The First People's Hospital of Lianyungang

    Breast Cancer

    approved small molecule active

    1 trial
  13. Pharmacotherapy

    The First People's Hospital of Lianyungang

    Diabetes Mellitus, Type 2

    approved small molecule active

    1 trial
  14. Phenylephrine

    United Therapeutics Europe Ltd

    Spinal Anesthesia

    approved small molecule terminated

    1 trial
  15. Pitolisant

    Harmony Biosciences Holdings

    Restless Legs Syndrome

    approved small molecule active

    1 trial
  16. Placebo for benralizumab for clinical trials is a sterile liquid solution presented in an accessorized prefilled syringe (apfs) for subcutaneous injection., Fasenra 30 mg solution for injection in pre-filled syringe

    AstraZeneca AB

    Severe eosinophilic asthma

    approved small molecule active

    1 trial
  17. Placebo of rosuvastatin 10mg (tablet) as produced by Apotheek A15, Rosuvastatin tablet 10mg Apotheek A15

    Disc Medicine

    Statin-intolerance, High cardiovascular risk (previous cardiovascular disease or familial hypercholesterolemia)

    approved small molecule active

    1 trial
  18. Placebo suspension is identical to Symbioflor®2 liquid formulation in appearance, weight and composition, with the exception that the active ingredient will be omitted. Placebo constitutes are sodium chloride, magnesium sulphate 7H2O, potassium chloride, calcium chloride 2H2O, magnesium chloride 6H2O, and purified water, Symbioflor 2 Tropfen zum Einnehmen, Suspension

    Alphapharm Pty Ltd

    Irritable Bowel Syndrome

    approved small molecule active

    1 trial
  19. Placebo to AIN457 150 mg/1 mL Solution for injection in pre-filled syringe, SECUKINUMAB

    Novartis Pharmaceuticals

    non-radiographic axial spondyloarthritis

    approved small molecule active

    1 trial
  20. Placebo used in this trial is a foodgrade, redried potato starch. It is a white powder with bland taste and free from objectionable odours. Insoluble in water with a temperature below 50 °C and most organic solvents, solution is slightly hazy. The product is intended for use in food., POTATO STARCH, SODIUM CHLORIDE, AMILORIDE

    Disc Medicine

    Autosomal Dominant Polycystic Kidney Disease

    approved small molecule active

    1 trial
  21. Placebo, Desloratadine 5 mg orodispersible tablets, Bactil Flas 10 mg Liofilizados orales, Bilaxten 20 mg comprimidos bucodispersables

    A. Menarini Industrie Farmaceutiche Riunite s.r.l.

    Allergy

    approved small molecule active

    1 trial
  22. Placebo: PL1, Pharmaceutical form: Capsule, Route of administration: Oral use, Hydrocortison DMB 20 mg, tabletten

    Disc Medicine

    Posttraumatic Stress Disorder (PTSD)

    approved small molecule active

    1 trial
  23. Plavix 75 mg film-coated tablets, CARDIOASPIRIN 100 mg Compresse gastroresistenti, CARDIOASPIRIN 100 mg Compresse gastroresistenti, Plavix 300 mg film-coated tablets

    Fondazione Telethon ETS

    Patients with atrial fibrillation undergoing percutaneous left atrial appendage closure with the Amulet device

    approved small molecule active

    1 trial
  24. Plavix 75 mg film-coated tablets, Clopidogrel Viatris 75 mg film-coated tablets, ACETYLSALICYLIC ACID , DIPYRIDAMOLE

    Disc Medicine

    Stroke

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources